SLC25A20 and hepatocellular carcinoma: In addition, FAO inhibition by etomoxir treatment significantly reversed SLC25A20-overexpression–suppressed-HCC-cell-growth-and-metastasis (Fig. 6F–I), indicating that SLC25A20 suppressed HCC growth and metastasis through activation of fatty-acid oxidation.